Transgenic rats set to join murine cousins in drug discovery
This article was originally published in Scrip
Rat germ-cell lines have been produced from embryonic stem cells, paving the way for the use of knock-out and knock-in transgenic rats in drug discovery.
You may also be interested in...
Amgen's investigational bone loss treatment denosumab more than halves osteoporosis patients' risk of new vertebral fractures, new data from a pivotal Phase III trial show.
GlaxoSmithKlineand Xenoporthave submitted an NDA to the US FDAfor the once-daily restless legs syndrome drug Solzira (gabapentin enacarbil extended-release tablets), previously known as GSK1838262 by GSK and XP13512 by Xenoport.